Clinical Data, Inc. Signs Contract with Aetna for In-network Coverage of FAMILION(R) Genetic Tests for Inherited Cardiac Syndromes

NEWTON, Mass.--(BUSINESS WIRE)--PGxHealth®, a division of Clinical Data, Inc. (NASDAQ: CLDA), announced today that it has become an in-network provider with Aetna for healthcare coverage of its FAMILION® family of genetic tests. By detecting genetic mutations, the FAMILION tests are used to recognize inherited forms of cardiac channelopathies, such as Long QT Syndrome (LQTS), and cardiomyopathies, such as Hypertrophic Cardiomyopathy (HCM), in individuals and their families and help to guide treatment decisions to prevent possible sudden cardiac death.